Alogliptin Benzoate

Overview

Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC 50 of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9 . Alogliptin Benzoate can be used for the research of type 2 diabetes.

Application

Products | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Cardiovascular Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Research Areas > Inflammation/Immunology | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Dipeptidyl Peptidase | Products > Signaling Pathways > Ferroptosis

Product Information

• Catalog No.: HY-A0023
• CAS No.: 850649-62-6
• Molecular Formula: C25H27N5O4
• Molecular Weight: 461.51
• Purity: 99.98%
• Storage: 4°C, sealed storage, away from moisture * In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
• Solubility: ≥ 1.25 mg/mL (2.71 mM); Clear solution
• Availability: In-stock

Source

Original product source